Prof. Yamanaka receives Balzan Prize for work on iPS cells

Prof. Yamanaka receives Balzan Prize for work on iPS cells

ROME, Italy - Shinya Yamanaka, professor at Kyoto University, holds up a certificate for the Balzan Prize in Rome on Nov. 19, 2010, after winning the award for his pioneering work in producing induced pluripotent stem cells, or iPS cells.

  • Product Code
  • ILEA001154378
  • Registered date
  • 2010/11/19 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2010 Kyodo News
  • Media size
  • 1410 × 1303 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 385.19(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Kariko, Weissman win Nobel medicine prize for COVID mRNA vaccine work

    Kariko, Weissman win Nobel medicine prize for COVID mRNA vaccine work

    University of Pennsylvania professor Drew Weissman arrives at the venue of a press conference at the university in Philadelphia, the United States, on Oct. 2, 2023, after being awarded this year's Nobel Prize in physiology or medicine jointly with his Hungarian research partner Katalin Kariko for their work leading to the development of COVID-19 vaccines using a new messenger RNA technology.
      World's 1st transplant of iPS heart muscle tissue

      World's 1st transplant of iPS heart muscle tissue

      Osaka University professor Yoshiki Sawa (L) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
        World's 1st transplant of iPS heart muscle tissue

        World's 1st transplant of iPS heart muscle tissue

        Osaka University professor Yoshiki Sawa (R) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
          World's 1st transplant of iPS heart muscle tissue

          World's 1st transplant of iPS heart muscle tissue

          Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
            World's 1st transplant of iPS heart muscle tissue

            World's 1st transplant of iPS heart muscle tissue

            Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
              World's 1st transplant of iPS heart muscle tissue

              World's 1st transplant of iPS heart muscle tissue

              Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
                World's 1st transplant of iPS heart muscle tissue

                World's 1st transplant of iPS heart muscle tissue

                Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
                  World's 1st test using iPS cells to treat corneal disease

                  World's 1st test using iPS cells to treat corneal disease

                  Osaka University professor Koji Nishida speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo
                    World's 1st test using iPS cells to treat corneal disease

                    World's 1st test using iPS cells to treat corneal disease

                    Osaka University professor Koji Nishida (2nd from R) speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo
                      Use of iPS cells to treat spinal cord injuries

                      Use of iPS cells to treat spinal cord injuries

                      Keio University professor Hideyuki Okano speaks in Tokyo on Feb. 18, 2019, about the use of induced pluripotent stem cells to treat patients suffering from the loss of motor function due to spinal cord injuries. (Kyodo) ==Kyodo